tiprankstipranks
Advertisement
Advertisement

TAK Stock Latest News

Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
The FlyTrump Trade: Trump says Xi agreed to buy 200 jets from Boeing
3d ago
BA
SPY
Justice Department announces $13.67M civil settlement with Takeda
PremiumThe Fly
Justice Department announces $13.67M civil settlement with Takeda
4d ago
TAK
These Are the Stocks Reporting Earnings Today – May 13, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – May 13, 2026
5d ago
MFC
STN
TAK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TAK Upcoming Earnings Report: What to Expect?
7d ago
TAK
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
PremiumCompany Announcements
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
11d ago
TAK
Takeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential
PremiumCompany AnnouncementsTakeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential
11d ago
TAK
Takeda announces TAK-881-3001 trial in PID met primary endpoint
Premium
The Fly
Takeda announces TAK-881-3001 trial in PID met primary endpoint
14d ago
TAK
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
Premium
Company Announcements
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
16d ago
TAK
Protagonist exercises right to opt out of 50:50 U.S. arrangement for rusfertide
PremiumThe Fly
Protagonist exercises right to opt out of 50:50 U.S. arrangement for rusfertide
20d ago
TAK
PTGX
Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
PremiumCompany Announcements
Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
25d ago
TAK
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
PremiumCompany Announcements
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
25d ago
TAK
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors
PremiumCompany Announcements
Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors
1M ago
TAK
Takeda’s Real-World Dengue Vaccine Study Could Reshape Its Emerging Markets Outlook
PremiumCompany AnnouncementsTakeda’s Real-World Dengue Vaccine Study Could Reshape Its Emerging Markets Outlook
1M ago
TAK
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
Premium
The Fly
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
1M ago
TAK
SYRE
Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
Premium
Company Announcements
Takeda Updates Early-Stage Multiple Myeloma Study for TAK-079, Signaling Ongoing Oncology Push
1M ago
TAK
Takeda upgraded to Outperform from Market Perform at Bernstein
PremiumThe Fly
Takeda upgraded to Outperform from Market Perform at Bernstein
1M ago
TAK
Denali Therapeutics regains full rights to DNL593
PremiumThe Fly
Denali Therapeutics regains full rights to DNL593
1M ago
TAK
DNLI
Abivax appoints Michael Nesrallah as chief commercial officer
PremiumThe Fly
Abivax appoints Michael Nesrallah as chief commercial officer
2M ago
TAK
ABVX
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
PremiumThe Fly
Axsome Therapeutics enters TAK-063 asset purchase agreement with Takeda
2M ago
TAK
AXSM
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
PremiumThe FlyAlumis shares should trade higher on ‘major success’ at AAD, says Ramond James
2M ago
JNJ
TAK
Alumis price target raised to $55 from $50 at Oppenheimer
Premium
The Fly
Alumis price target raised to $55 from $50 at Oppenheimer
2M ago
JNJ
TAK
Takeda announces new data from Phase 3 studies of TAK-279
Premium
The Fly
Takeda announces new data from Phase 3 studies of TAK-279
2M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >